RescueDoppler- a Disruptive Ultrasound Solution for Improved Outcome After Cardiac Arrest. (NCT06599073) | Clinical Trial Compass
CompletedNot Applicable
RescueDoppler- a Disruptive Ultrasound Solution for Improved Outcome After Cardiac Arrest.
Norway, Sweden285 participantsStarted 2024-09-19
Plain-language summary
RescueDoppler is an innovative, hands-free Doppler system designed for continuous monitoring of blood flow in the carotid artery, distinguishing between the presence and absence of a pulse. It is non-invasive, user-independent, and does not require specialized ultrasound expertise. The primary goal of this study is to assess the feasibility and clinical utility of RescueDoppler for monitoring carotid artery blood flow in patients experiencing sudden cardiac arrest.
The multi-center study will be performed both pre-hospital and in-hospital.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Male or female, aged 18 years or older. Subjects experiencing a sudden cardiac arrest, either pre-hospital or in-hospital. Sudden cardiac arrest is defined as the abrupt loss of heart function, breathing, and consciousness.
Exclusion Criteria:
Subjects where resuscitation is not continued after the initial application of RescueDoppler or resuscitation efforts are halted due to a do-not-resuscitate order.
Subjects deemed unable to comply with the study requirements as determined by the Investigator.
Subjects with extensive trauma injuries that prevent proper attachment of the RescueDoppler patch.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial focused on measuring carotid blood flow velocity during CPR using Doppler ultrasound — is this kind of real-time blood flow monitoring something our hospital currently uses, or could use, during cardiac arrest resuscitation?
2Since this study is already completed, has my doctor seen any of the results yet, and do the findings about whether patients achieved adequate carotid blood flow during CPR change how resuscitation might be approached in my situation?
3The trial used a specific threshold of 20 cm per second of carotid peak blood flow velocity as a key measurement — can my doctor explain what achieving or not achieving that level during CPR might mean for outcomes, based on what this study found?
4Because this was listed as 'phase NA,' meaning it wasn't testing a drug but rather a monitoring technique, how might adding Doppler ultrasound guidance during CPR differ from standard resuscitation practice, and would it realistically be available to me?
5Are there other ongoing studies or current clinical protocols building on this kind of Doppler-guided CPR monitoring that my doctor thinks might be relevant to my care or my family's emergency planning?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of patients with carotid peak blood flow velocity of more than 20 cm/second during cardiopulmonary resuscitation
Timeframe: From enrollment to the end after 12 months
Trial details
NCT IDNCT06599073
SponsorNorwegian University of Science and Technology